Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB13929ExperimentalSmall molecule
Relcovaptan: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Oxytocin receptor and Vasopressin V1a receptor
- Formula / weight
- C28H27Cl2N3O7S · 620.5 g/mol (avg)
- Code names
- SR-49059 · TDI-0134
Resolves to
Structure
InChIKey
CEBYCSRFKCEUSW-NAYZPBBASA-NSMILESCOC1=CC=C(C=C1OC)S(=O)(=O)N1[C@@H](C(=O)N2CCC[C@H]2C(N)=O)[C@](O)(C2=CC(Cl)=CC=C12)C1=CC=CC=C1ClTargets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Relcovaptan, and which of those have an active Phase 3 trial?